Electroconvulsive seizures increase levels of pGlu-Glu-Pro-NH2 (EEP) in rat brain

Peptides

Volumn 20, Issue 1, 1999, Pages 107-119

  Pekary, A Eugene ^a,c   Sattin, Albert ^a,b,d   Lloyd, R L ^d,e  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Internal Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

Affective disorders; Antidepressant; Blood brain barrier; EEP; Electroconvulsive seizures; Forced swim test; HPLC; Radioimmunoassay; Rat brain; TRH

Indexed keywords

ANTIDEPRESSANT AGENT; PROTIRELIN; PYROGLUTAMYLGLUTAMYLPROLINAMIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; DRUG CLEARANCE; ELECTROCONVULSIVE THERAPY; FORCED SWIMMING TEST; HIPPOCAMPUS; HORMONE DETERMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTOR CORTEX; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PYRIFORM CORTEX; RADIOIMMUNOASSAY; RAT; SEIZURE;

EID: 0032897313     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00140-5     Document Type: Article

References (60)

1. Abraham G.E., Grover P.K. Covalent linkage of hormonal haptens to protein carriers for use in radioimmunoassay. Odell W.D., Daughaday W.H. Principles of Competitive Protein-Binding Assays. 1971;134-139 Lippincott, Philadelphia.
2. Akinsanya K.O., Ghatei M.A., Bloom S.R. Gonadal steroids regulate rat anterior pituitary levels of TSH-releasing hormone- and pyroglutamyl-glutamyl-proline amide-like immunoreactivity. Endocrinology. 136:1995;734-740.
3. Baura G.E., Foster D.M., Porte D. Jr, Kahn S.E., Bergman R.N., Cobelli C., Schwartz M.W. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. J. Clin. Invest. 92:1993;1824-1830.
4. Boiteux J., Roubaud L., Gandelet N., Nezelof S., Vittouris N., Bonin B., Sechter D., Bizouard P. Indications for electroconvulsive therapy. Encephale. 23:1997;21-26.
5. Boler J., Enzmann F., Folkers K., Bowers C.Y., Schally A.V. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem. Biophys. Res. Commun. 37:1969;705-710.
6. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology. 94:1988;147-160.
7. 2 sequence. C.R. Acad. Sci. Hebd. Seances Acad. Sci., Ser. D Sci. Natur. 269:1969;1870-1873.
8. Busby W.H. Jr, Quackenbush G.E., Humm J., Youngblood W.W., Kiser J.S. An enzyme(s) that converts glutamyl-peptides into pyroglutamyl peptides. J. Biol. Chem. 262:1987;8532-8536.
9. Callahan A.M., Frye M.A., Marangell L.B., George M.S., Ketter T.A., L'Herrou T., Post R.M. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: Effects of tolerance and implications for therapeutics. Biol. Psych. 41:1997;264-272.
10. Cockle S.M., Aitken A., Beg F., Smyth D.G. A novel peptide, pyroglutamylglutamylproline amide, in the rabbit prostate complex, structurally related to thyrotropin-releasing hormone. J. Biol. Chem. 264:1989;7788-7791.
11. Cockle S.M., Prater G.V., Thetford C.R., Hamilton C., Malone P.R., Mundy A.R. Peptides related to thyrotrophin-releasing hormone (TRH) in human prostate and semen. Biochim. Biophys. Acta. 1227:1994;60-66.
12. del Rio-Garcia J., Smyth D.G. Distribution of pyroglutamylpeptide amides related to thyrotropin-releasing hormone in the central nervous sytem and periphery of the rat. J. Endocrinol. 127:1990;445-450.
13. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. 121:1995;66-72.
14. Fleischhacker W.W., Hinterhuber H., Bauer H., Pflug B., Berner P., Simhandl C., Wolf R., Gerlach W., Jaklitsch H., Sastre-y-Hernandez M., et al. A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology. 26:1992;59-64.
15. Gershengorn M.C., Osman R. Molecular and cellular biology of thyrotropin-releasing hormone receptors. Physiol. Rev. 76:1996;175-191.
16. Green C.M., Cockle S.M., Watson P.F., Fraser L.R. A possible mechanism of action for fertilization promoting peptide, a TRH-related tripeptide that promotes capacitation and fertilizing ability in mammalian spermatozoa. Mol. Reprod. Dev. 45:1996;244-252.
17. Heuer H., Schafer M.K.-H., Westermann R., Bauer K. mRNA distribution of the thyrotropin-releasing hormone (TRH)-degrading ectoenzyme in rat CNS and pituitary. Soc. Neurosci. 23:(part 2):1997;2031. [Abstract].
18. Hyde T.M., Bachus S.E., Xhi Z.X., Herman M.M., Kleinman J.E. Am. Coll. Neuropsychopharmacol. 1996;. [Abstract].
19. Itoh Y., Ogasawara T., Yamazaki A., Ukai Y., Miura A., Kimura K. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolineamide, as studied by intracerebral microdialysis. J. Pharm. Exp. Ther. 268:1994;255-261.
20. Kastin A.J., Ehrensing R.H., Schalch D.S., Anderson M.S. Improvement in mental depression with decreased thyrotropin response after administration of TRH. Lancet. ii:1972;740-742.
21. Kato K., Yang H., Tache Y. Low doses of TRH analog act in the dorsal motor nucleus to induce gastric protection in rats. Am. J. Physiol. 269:1995;R1301-R13087.
22. Klootwijk W., de Boer R.D.H., Sleddens-Linkels E., Cockle S.M., de Herder W.W., Bauer K., de Greef W.J. Urinary excretion of the TRH-like peptide pyroglutamyl-glutamyl-prolineamide in rats. J. Endocrinol. 153:1997;411-421.
23. Klootwijk W., de Herder W.W., Kwekkeboom D.J., Lamberts S.W.J., Krenning E.P., Visser T.J., de Greef W.J. High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors. J. Clin. Endocrinol. Metab. 81:1996;2816-2820.
24. Klootwijk W., Sleddens-Linkels E., de Boer R., Jansen C.A., Autar R., de Herder W.W., Boeve E.R., Visser T.J., de Greef W.J. Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans. J. Clin. Endocrinol. Metab. 82:1997;3068-3073.
25. Kubek M.J., Knoblach S.M., Sharif N.A., Burt D.R., Buterbaugh G.G., Fuson K.S. TRH gene expression and receptors are differentially modified in limbic foci by seizures. Ann. Neurol. 33:1993;70-76.
26. Kubek M.J., Low W.C., Sattin A., Morzorati S.L., Meyerhoff J.L., Larsen S.H. Role of TRH in seizure modulation. Ann. NY Acad. Sci. 553:1989;286-303.
27. Lechan R.M., Wu P., Jackson I.M.D., Wolf H., Cooperman S., Mandel G., Goodman R.H. Thyrotropin-releasing hormone precursor: Characterization in rat brain. Science. 231:1986;159-161.
28. Lexow N., Joyce J.N., Kim S.J., Phillips J., Casanova M.F., Bird E.D., Kleinman J.E., Winokur A. Alterations in TRH receptors in temporal lobe of schzophrenics a quantitative autoradiographic study . Synapse. 18:1994;315-327.
29. Lloyd R.L., Pekary A.E., Sattin A. Antidepressant effects of a stable analogue of thyrotropin releasing hormone in a rodent model of depression. Soc. Neurosci. 23:(Part 2):1997;1661. [Abstract].
30. 2) in the rat. Br. J. Pharmacol. 110:1997;178P. [Abstract].
31. Manin M., Broer Y., Balage M., Rostene W., Grizard J. Metabolic clearance of insulin from the cerebrospinal fluid in the anesthetized rat. Peptides. 11:1990;5-12.
32. Marangell L.B., Callahan A., George M., Ketter T., Pazzaglia P., L'Herrou T., Leverich G.L., Post R.M. Effects of intrathecal thyrotropin-releasing hormone (TRH) in refractory depressed patients. Arch. Gen. Psychiat. 54:1997;214-222.
33. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16:1996;2365-2372.
34. O'Cuinn G. Metabolism of Brain Peptides. 1995;CRC Press, Boca Raton.
35. Ogawa N., Mizuno S., Mori A., Nukina I., Ota Z., Yamamoto M. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues. Peptides. 5:1984;743-746.
36. Paul I.A., Duncan G.E., Hong J.S., Mueller R.A., Iksander N., Breese G.R. A comparison of the regional effects of antidepressant drugs and chronic electroconvulsive shock on beta-adrenergic receptors, thyrotropin-releasing hormone- and dynorphin (1-8)-like immunoreactivity in rat brain. Soc. Neurosci. 12:1986;416. [Abstract].
37. Pekary A.E. Parallel line and relative potency analysis of bioassay and radioimmunoassay data using a desk top computer. Comput. Biol. Med. 9:1979;355-362.
38. Pekary A.E., Hershman J.M., Sugawara M., Gieschen K.I., Sogol P.B., Rood A.W., Pardridge W.M., Walfish P.G. Preferential release of triiodothyronine: an intrathyroidal adaptation to reduced serum thyroxine in aging rats. J. Geront. 38:1983;653-659.
39. 2 (EEP) levels in rat limbic system. Soc. Neurosci. 23:(Part 2):1997;2377. [Abstract].
40. Pekary A.E., Lukaski H.C., Mena I., Hershman J.M. Processing of TRH precursor peptides in rat brain and pituitary is zinc dependent. Peptides. 12:1991;1025-1032.
41. Pekary A.E., Lukaski H.C., Mena I., Smith S.M., Bhasin S., Hershman J.M. Testosterone increases TRH biosyonthesis in epididymis but not heart of zinc-deficient rats. Peptides. 14:1993;315-324.
42. 3im-methyl-histidyl-prolineamide (methyl-thyrotropin releasing hormone) in the rat hypothalamus. J. Endocrinol. 77:1978;405-408.
43. Pekary A.E., Sattin A., Lloyd R.L. Electroconvulsive seizures increase levels of PS4, the TRH enhancing peptide [prepro-TRH(160-167)], in rat brain. Neuroendocrinology. 65:1997;377-384.
44. Pekary A.E., Stephens R., Simard M., Pang X.-P., Smith V., DiStefano J.J. III, Hershman J.M. Release of TSH and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: Conversion to TRH is sufficient for in vivo effects. Neuroendocrinology. 52:1990;618-625.
45. Porsolt R.D., Anton G., Blavel N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 47:1978;379-391.
46. Prange A.J. Jr, Wilson I.C., Lara P.D., Alltop L.B., Breese G.R. Effects of TRH in depression. Lancet. ii:1972;999-1002.
47. Prigge S.T., Kolhekar A.S., Eipper B.A., Maines R.E., Amzel L.M. Amidation of bioactive peptides: the structure and peptidylglycine α-hydroxylating monooxygenase. Science. 278:1997;1300-1305.
48. Reichlin S. Neuroendocrine Control of Thyrotropin Secretion. Ingbar S.H., Braverman L.E. Werner's The Thyroid. Fifth Edition :1986;241-266 Lippincott, London.
49. Rivier J., Vale W., Monahan M., Ling N., Burgus R. Synthetic thyrotropin-releasing factor analogs. 3. Effect of replacement or modification of histidine residue on biological activity. J. Med. Chem. 15:1972;479-482.
50. Rondeel J.M., de Jong F.H., van Haasteren G.A. Further studies on the regulation, localization and function of the TRH-like peptide pyroglutamyl-glutamyl-prolineamide in the rat anterior pituitary. J. Endocrinol. 146:1995;293-300.
51. Rondeel J.M., Klootwijk W., Linkels E., deGreef W.J., Visser T.J. Neural differentiation of the human neuroblastoma cell line IMR32 induces production of a thyrotropin-releasing hormone-like peptide. Brain Res. 665:1994;262-268.
52. Sackeim H.A. Central issues regarding the mechanisms of action of electroconvulsive therapy: Directions for future research. Psychopharm. Bull. 30:1994;281-308.
53. Sackeim H.A., Devanand D.P., Prudic J. Stimulus intensity, seizure threshold and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy. Psych. Clin. N. Am. l4:1991;803-843.
54. Sattin A. A possible role for Thyrotropin-Releasing Hormone (TRH) in antidepressant treatment. Ehrlich Y.H., Lenox R.H., Kornecki E., Berry W.O. Molecular Mechanisms of Neuronal Responsiveness. 1987;549-555 Plenum Press, New York.
55. Sattin A., Pekary A.E., Lloyd R.L. TRH gene products are implicated in the antidepressant mechanisms of seizures. Ann. NY Acad. Sci. 739:1994;135-153.
56. Sattin A., Pekary A.E., Lloyd R.L. An animal model of therapeutic versus non-therapeutic seizures. Soc. Neurosci. 21:1995;1736. [Abstract].
57. Schauder B., Schomburg L., Kohrle J., Bauer K. Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone. Proc. Natl. Acad. Sci. USA. 91:1994;9534-9538.
58. Schwartz M.W., Sipols A., Kahn S.E., Lattemann D.F., Taborsky G.J. Jr, Bergman R.N., Woods S.C., Porte D. Jr. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am. J. Physiol. 259:1990;E378-E383.
59. Sharp T., Bennett G.W., Marsden C.A. Thyrotropin-releasing hormone analogs increase dopamine release from slices of rat brain. J. Neurochem. 39:1982;1763-1766.
60. Vonhof S., Feuerstein G.Z., Cohen L.A., Labroo V.M. Norvaline2-TRH: binding to TRH receptors in rat brain homogenates. Eur. J. Pharmacol. 180:1990;1-12.